Search Results - G. Pretelli

PragmaTIL: A randomized phase II study evaluating an IL-2 analogue (ANV419) versus high-dose IL-2 following tumor-infiltrating lymphocyte (TIL) therapy in advanced melanoma. by M.J. Lostes Bardaji, V. Galvao, I. Mansfield Noringriis, R. Haunstrup Døssing, S. Klobuch, G. Pretelli, G. Villacampa, A. Lundqvist, S.L. Wickström, M. Donia, V. García-Patos Briones, C. Ferrándiz Pulido, E. Muñoz Couselo, M.A. Franzoi, P. Cacilhas, G. Jacob, F. Le Moal, S. Everhard, I. Creus, X. Villalobos, M. Monràs, M. Moreno, I. López, N. García Pazos, R. Shapira, I. Vaz Luis, R. Kiessling, S. Martin Lluesma, A. Gros, J. Haanen, I.M. Svane, E. Garralda Cabanas

Get full text